FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for administering hydrazide of 2-[3-methyl-7-(thietanyl-3)-1-ethylxanthinyl-8-tio]acetic acid of formula:
as an agent possessing antidepressant activity.
EFFECT: invention allows using the said compound in depressive disorders.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 5-BROMO-2-(THIETAN-3-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE DERIVATIVES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2011 |
|
RU2459818C1 |
| 2-BROMO-1-(THIETANYL-3)IMIDAZOLE-4,5-DICARBOXYLIC ACID DERIVATIVES EXHIBITING ANTIDEPRESSANT ACTIVITY | 2014 |
|
RU2537948C1 |
| METHOD OF CORRECTING DEPRESSIVE DISORDERS BY THIETAN-1,1-DIOXIDE DERIVATIVES IN EXPERIMENT | 2010 |
|
RU2424799C1 |
| 1-(1,1-DIOXOTIETHAN-3-yl)-4-(2-OXO-2-PHENYLETHIL)-1,2,4-TRIAZOL-4-th BROMIDE, SHOWING ANTIDEPRESSIVE ACTIVITY | 2022 |
|
RU2785340C1 |
| 5-AMINO-SUBSTITUTED 3-BROMO-4-NITRO-1-(THIETAN-3-YL)-1H-PYRAZOLES EXHIBITING ANTIDEPRESSANT ACTIVITY | 2023 |
|
RU2817972C1 |
| DERIVATIVES OF 4,6-DIMETHYL-2,3-DIHYDRO-1H-PYRAZOLO[4,3-c] PYRIDINE-3-ONES AND ETHERS 2,6-DIMETHYL-4-PHENYL-HYDRAZINE NICOTINIC ACIDS AS INTERMEDIATE PRODUCTS FOR THEIR SYNTHESIS, POSSESSING ANTIDEPRESSANT AND ANXIOLYTIC POTENCY | 2007 |
|
RU2394034C2 |
| "FLUOGLYSINE" MEDICINAL PREPARATION FOR TREATING DIFFERENT FORMS OF DEPRESSION | 2002 |
|
RU2232574C2 |
| 5-AMINE-SUBSTITUTED THIETHANE-CONTAINING 3-BROMO-4-NITROPYRAZOLES WITH ANTIDEPRESSANT ACTIVITY | 2022 |
|
RU2801039C1 |
| DERIVATIVES OF 3-METHYL-7-(THETANYL-3)-XANTHINE POSSESSING HEMORHEOLOGICAL ACTIVITY | 2006 |
|
RU2316551C1 |
| CYCLOHEXYL AMMONIUM SALT OF 2-[3-METHYL-7-(1,1-DIOXOTIETHANYL-3)-1-ETHYL XANTHENYL-8-TIO]ACETIC ACID, WHICH SHOWS ANTITHROMBOEMBOLIC ACTION | 2012 |
|
RU2504546C1 |
